Garo H. Armen - Oct 6, 2023 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chairman and Chief Executive Officer, Director
Signature
/s/Christine M. Klaskin, as Attorney-in-Fact for Garo H. Armen
Stock symbol
AGEN
Transactions as of
Oct 6, 2023
Transactions value $
$16,223
Form type
4
Date filed
10/10/2023, 09:00 AM
Previous filing
Sep 25, 2023
Next filing
Oct 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $16.2K +15.3K +1.2% $1.06 1.29M Oct 6, 2023 Direct F1, F2
holding AGEN Common Stock 126K Oct 6, 2023 See footnote F3
holding AGEN Common Stock 579K Oct 6, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 6, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
F2 $1.06 is the closing price of our Common Stock on October 6, 2023, the payroll date for the pay period ending October 6, 2023.
F3 Shares are held in Dr. Armen's IRA accounts.
F4 Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 479,000 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 100,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Remarks:

Chairman and Chief Executive Officer